Skip to main content

Table 5 Haplotype analysis of three-SNP NOD1 haplotype in IBD patients and Caucasians in a New Zealand population.

From: Nucleotide-binding oligomerization domain containing 1 (NOD1) haplotypes and single nucleotide polymorphisms modify susceptibility to inflammatory bowel diseases in a New Zealand caucasian population: a case-control study

  Haplotype Case subject frequency (%) Control subject frequency (%) p-value OR (95% CI) Global score statistics
CD Three SNPs NOD1gregion      
  (rs2075818, rs2075822, rs2907748)      
  CCA 20.6 22.2 0.53 0.90 (0.67–1.21) χ2 = 9.55,
  CTG 55.8 46.9 0.004 1.44 (1.12–1.85) df = 3,
  GTA 3.3 4.2 0.25 0.77 (0.41–1.45) p = 0.02
  GTG 16.0 21.7 0.02 0.68 (0.50–0.92)  
UC Three SNPs NOD1gregion
(rs2075818, rs2075822, rs2907748)
     
  CCA 19.5 22.2 0.23 0.83 (0.62–1.11) χ2 = 2.30,
  CTG 51.9 46.9 0.14 1.19 (0.93–1.52) df = 3,
  GTA 3.8 4.2 0.79 0.89 (0.48–1.63) p = 0.51
  GTG 21.5 21.7 0.95 0.97 (0.72–1.30)